Manuscripts

Search by keyword, year, or author name.

Showing 1591 manuscripts.

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells

Tracey King, Lane R. Bushman, B.Ch., Jennifer J. Kiser, Pharm.D., Peter Anderson, Pharm.D., M. Graham Ray, R.N., M.S.N., Tom Delahunty, Courtney V. Fletcher, Pharm.D. Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences. 2006 Aug 01; 843(2006):147-56.

Year

2006

Journal

Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences

HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml

Yumi Mitsuya, Mark A. Winters, M.S., W. Jeffrey Fessel, M.D., Soo-Yon Rhee, Sally Slome, M.S., Michael Horberg, Leo Hurley, Jason Flamm, M.D., Daniel Klein, M.D., Robert Shafer, M.D. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml. Journal of Acquired Immune Deficiency Syndromes. 2006 Sep 01; 43(1):56-59.

Year

2006

Journal

Journal of Acquired Immune Deficiency Syndromes

A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086

Constance A. Benson, M.D., Florin Vaida, Ph.D., Diane V. Havlir, M.D., Gerald F. Downey, M.Sc., Michael M. Lederman, M.D., Roy (Trip) Gulick, M.D., M.P.H., Marshall Jay Glesby, M.D., Ph.D., Michael Wantman, Christian J. Bixby, B.S., Alex R. Rinehart, Ph.D., Sally Snyder, B.S., Rui Wang, M.S., Sheran Patel, D.O., John W. Mellors, M.D. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. Journal of Infectious Diseases. 2006 Nov 01; 194(9):1309-18.

Year

2006

Journal

Journal of Infectious Diseases

Antibody responses to Hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy: P1008

Adriana Weinberg, M.D., Philimon Gona, Ph.D., Sharon Appelbaum Nachman, M.D., Patricia Alexandra Defechereux, Ph.D., Ram Yogev, M.D., Walter T. Hughes, M.D., Diane W. Wara, M.D., Carol Elgie, B.S., Marlene A. Cooper, M.S., Wayne M. Dankner, M.D. Antibody responses to Hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy: P1008. Journal of Infectious Diseases. 2006 Jan 15; 193(2):302-311.

Year

2006

Journal

Journal of Infectious Diseases

Study

P1008

A history of pediatric immunology.

E. Richard Stiehm, M.D., Richard B. Johnston, Jr. A history of pediatric immunology. Pediatric Research. 2006 Mar 20; 57(3):458-467.

Year

2006

Journal

Pediatric Research

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.

Myron Levin, M.D., Anne A. Gershon, M.D., Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Barbara Nowak, B.A. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. Journal of Infectious Diseases. 2006 Jul 15; 194(2):247 - 255. PMID: 16779732.

Year

2006

Journal

Journal of Infectious Diseases

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

Philimon Gona, Ph.D., Russell B. Van Dyke, M.D., Paige L. Williams, Ph.D., Wayne M. Dankner, M.D., Miriam Chernoff, Ph.D., Sharon Appelbaum Nachman, M.D., George Seage, III, Sc.D., M.P.H. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. The Journal of the American Medical Association. 2006 Jul 19; 296(3):292 - 300. PMID: 16849662.

Year

2006

Journal

The Journal of the American Medical Association

Play the Winner for Phase II/III Clinical Trials.

Qing Yao, Ph.D. Play the Winner for Phase II/III Clinical Trials. Statistics In Medicine. 2006 Apr 19; 15(21-22):2413-2423.

Year

2006

Journal

Statistics In Medicine

Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clin

Andrew A. Wiznia, M.D., Kenneth Stanley, Ph.D., Paul Krogstad, M.D., George M. Johnson, M.D., Sophia S. Lee, M.S., James McNamara, M.D., John ( Jack ) Moye, Jr., M.D., Brooks Jackson, M.D., M.B.A., Hermann A. Mendez, M.D., Rosaura M. Aguayo, M.D., Arry Dieudonne, M.D., Andrea Kovacs, M.D., Mahrukh Bamji, M.D., Elaine J. Abrams, M.D., Sohail R. Rana, M.D., John L. Sever, M.D., Ph.D., Sharon Appelbaum Nachman, M.D. Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clin. AIDS Research and Human Retroviruses. 2006 Mar 29; 16(12):1113-1121.

Year

2006

Journal

AIDS Research and Human Retroviruses